Relationship of the metabolic syndrome to carotid ultrasound traits

Cardiovascular Ultrasound

Volumn 4, Issue , 2006, Pages

  Pollex, Rebecca L ^a   Al Shali, Khalid Z ^a   House, Andrew A ^b   Spence, J David ^a,b   Fenster, Aaron ^a   Mamakeesick, Mary ^c   Zinman, Bernard ^d   Harris, Stewart B ^b   Hanley, Anthony J G ^d,e   Hegele, Robert A ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c Sandy Lake First Nation   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; CANADA; CAROTID ARTERY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ECHOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; ULTRASOUND;

ADULT; CANADA; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUNICA INTIMA;

EID: 33747081369     PISSN: 14767120     EISSN: 14767120     Source Type: Journal    
DOI: 10.1186/1476-7120-4-28     Document Type: Article

References (25)

1. Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Visseren FL: The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2004, 25(4):342-348.
2. Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005, 28(7):1769-1778.
3. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24(4):683-689.
4. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288(21):2709-2716.
5. Rajaram V, Pandhya S, Patel S, Meyer PM, Goldin M, Feinstein MJ, Neems R, Liebson PR, Fiedler BM, Macioch JE, Feinstein SB: Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy. Am J Cardiol 2004, 93(11A):32C-48C.
6. Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, Spence JD: 3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke 2005, 36(9):1904-1909.
7. Pollex RL, Spence JD, House AA, Fenster A, Hanley AJ, Zinman B, Harris SB, Hegele RA: A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes. Cardiovasc Ultrasound 2005, 3:15.
8. Spence JD: Ultrasound measurement of carotid plaque as a surrogate outcome for coronary artery disease. Am J Cardiol 2002, 89(4A):10B-15B; discussion 15B-16B.
9. Al-Shali K, House AA, Hanley AJ, Khan HM, Harris SB, Mamakeesick M, Zinman B, Fenster A, Spence JD, Hegele RA: Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions. Atherosclerosis 2005, 178(2):319-325.
10. Hegele RA, Al-Shali K, Khan HM, Hanley AJG, Harris SB, Mamakeesick M, Zinman B, Fenster A, Spence JD, House AA: Carotid ultrasound in one, two and three dimension. Vasc Dis Prevention 2005, 2:87-92.
11. Pollex RL, Hanley AJ, Zinman B, Harris SB, Khan HM, Hegele RA: Metabolic syndrome in aboriginal Canadians: Prevalence and genetic associations. Atherosclerosis 2006, 184(1):121-129.
12. Hanley AJG, Harris SB, Barnie A, Gittelsohn J, Wolever TMS, Logan A, Zinman B: The Sandy Lake Health and Diabetes Project: design, methods and lessons learned. Chronic Dis Canada 1995, 16:149-156.
13. Gittelsohn J, Wolever TM, Harris SB, Harris-Giraldo R, Hanley AJ, Zinman B: Specific patterns of food consumption and preparation are associated with diabetes and obesity in a Native Canadian community. J Nutr 1998, 128(3):541-547.
14. Harris SB, Zinman B, Hanley A, Gittelsohn J, Hegele R, Connelly PW, Shah B, Hux JE: The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population. Diabetes Res Clin Pract 2002, 55(2):165-173.
15. Kriska AM, Hanley AJ, Harris SB, Zinman B: Physical activity, physical fitness, and insulin and glucose concentrations in an isolated Native Canadian population experiencing rapid lifestyle change. Diabetes Care 2001, 24(10):1787-1792.
16. Hanley AJG, Harris SB, Mamakeesick M, Goodwin K, Fiddler E, Hegele RA, McLaughlin JR, Zinman B: Complications of type 2 diabetes among aboriginal Canadians: increasing our understanding of prevalence and risk factors. Canadian J Diabetes 2003, 27:455-463.
17. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285(19):2486-2497.
18. Selzer RH, Hodis HN, Kwong-Fu H, Mack WJ, Lee PL, Liu CR, Liu CH: Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. Atherosclerosis 1994, 111(1):1-11.
19. Landry A, Spence JD, Fenster A: Measurement of carotid plaque volume by 3-dimensional ultrasound. Stroke 2004, 35(4):864-869.
20. McNeill AM, Rosamond WD, Girman CJ, Heiss G, Golden SH, Duncan BB, East HE, Ballantyne C: Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study). Am J Cardiol 2004, 94(10):1249-1254.
21. Iglseder B, Cip P, Malaimare L, Ladurner G, Paulweber B: The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke 2005, 36(6):1212-1217.
22. Harris SB, Gittelsohn J, Hanley A, Barnie A, Wolever TM, Gao J, Logan A, Zinman B: The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care 1997, 20(2):185-187.
23. Al-Shali KZ, House AA, Hanley AJ, Khan HM, Harris SB, Zinman B, Mamakeesick M, Fenster A, Spence JD, Hegele RA: Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis. Stroke 2004, 35(9):2036-2040.
24. Hegele RA, Al-Shali KZ, House AA, Hanley AJ, Harris SB, Mamakeesick M, Fenster A, Zinman B, Cao H, Spence JD: Disparate associations of a functional promoter polymorphism in PCK1 with carotid wall ultrasound traits. Stroke 2005, 36(12):2566-2570.
25. Wallenfeldt K, Hulthe J, Fagerberg B: The metabolic syndrome in middle-aged men according to different definitions and related changes in carotid artery intima-media thickness (IMT) during 3 years of follow-up. J Intern Med 2005, 258(1):28-37.